BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 1, 2026
Home
»
Topics
» Dermatologic, BioWorld Science
Dermatologic, BioWorld Science
RSS
CollaGenex expands into dermatology
Jan. 17, 2002
Synthetic selectin antagonist OJ-R9188 may be useful in Rx of atopic dermatitis
Jan. 14, 2002
Solaraze now being marketed for actinic keratosis in U.S.
Jan. 11, 2002
First patients treated in phase II trial of PhotoPoint drug MV-9411 in psoriasis
Jan. 11, 2002
Alexion's 5G1.1 completes phase I pilot study
Jan. 10, 2002
Life Medical Sciences given green light for trial of Repel-CV in neonatal patients
Jan. 9, 2002
Chugai researchers design vitamin D3 analogues with antipsoriatic activity
Jan. 4, 2002
Pharmacia granted rights to foam delivery technology for use with Rogaine
Jan. 4, 2002
GSK discontinues development of ADL-2-1294
Dec. 27, 2001
SkyePharma withdraws Solaraze termination notice
Dec. 27, 2001
Previous
1
2
…
319
320
321
322
323
324
325
326
327
…
416
417
Next
RSS